The Safety Controls & Devices Limited IPO is an upcoming book‑built issue set to hit…

Sai Parenterals IPO Date, Price & Details 2026
Sai Parenterals IPO is an upcoming mainboard IPO from the pharmaceutical sector. The company has received approval from SEBI and plans to raise funds for expansion and business growth.
As per latest updates, the IPO is expected to open in March 2026, attracting strong interest from investors.

Sai Parenterals IPO Details
| Details | Information |
|---|---|
| IPO Type | Mainboard IPO |
| Face Value | ₹5 per share |
| Price Band | ₹372 – ₹392 per share |
| Issue Size | ₹425 Crores (Approx) |
| Fresh Issue | ₹285 Crores |
| Offer for Sale | 35 Lakh Shares |
| Listing Exchange | BSE & NSE |
Sai Parenterals IPO Dates
| Event | Date |
|---|---|
| IPO Open Date | March 24, 2026 |
| IPO Close Date | March 27, 2026 |
| Anchor Bidding | March 23, 2026 |
| Allotment Date | March 28, 2026 (Expected) |
| Listing Date | Early April 2026 (Tentative) |
Sai Parenterals IPO GMP
| GMP | Status |
|---|---|
| Latest GMP | Not Available |
Currently, Grey Market Premium (GMP) is not available, but it may update closer to the IPO date.
About the Company
Sai Parenterals Limited is a pharmaceutical company engaged in branded generic formulations and contract manufacturing (CDMO).
The company plans to use IPO funds for:
- Expanding manufacturing capacity
- Research & development
- Debt repayment
- General corporate purposes
Important Note for Investors
- IPO is expected to open soon in March 2026
- GMP is not available yet
- Pharma sector IPOs usually attract good demand
- Always check financials before investing